Dr. Jayanti Khura is a dedicated and empathetic physician specializing in Internal Medicine, with over five years of post-graduation experience in managing a wide range of medical conditions in hospital settings. She has developed a reputation for her clinical acumen, patient-cen...
Dr. Jayanti Khura is a dedicated and empathetic physician specializing in Internal Medicine, with over five years of post-graduation experience in managing a wide range of medical conditions in hospital settings. She has developed a reputation for her clinical acumen, patient-centered approach, and commitment to delivering high-quality healthcare. Her expertise spans from diagnosing complex medical conditions to developing personalized treatment strategies and counseling patients on preventive care and lifestyle adjustments.
Dr. Khura holds an MD in General Medicine from ABVIMS & Dr. RML Hospital, New Delhi, and an MBBS from SCB Medical College, Cuttack, Odisha. She has further enhanced her expertise by completing a certification course in diabetes from the Royal College of Physicians (RCP), London, and Fortis C-DOC Hospital, reflecting her commitment to continuous learning and specialization.
Research and Publications
Dr. Khura’s passion for research is reflected in her contributions to the medical field through several publications in renowned journals. She has explored topics like non-alcoholic fatty liver disease, inflammatory markers, and the correlation between COPD and bone health, making valuable contributions to the understanding of chronic diseases. Some of her notable works include:
Pro-inflammatory Markers in Non-Alcoholic Fatty Liver Disease: This study investigated the correlation between inflammatory markers IL-6 and TNF-alpha with fatty liver disease, highlighting potential diagnostic markers.
Kikuchi-Fujimoto Disease – A Clinical Enigma: A rare condition documented through two case reports, shedding light on the diagnosis and management of this disease.
Osteopenia and Osteoporosis in COPD Patients: A study evaluating the prevalence of bone density disorders in COPD patients, and their association with disease severity.
Read More
Read Less